Investor Resources
CSE: PMED
OTC MARKETS: PMEDF
FRA: 3QP
About Predictmedix
Predictmedix is a Life Sciences technology company developing AI-powered products to improve workplace health and safety, enhance protection in public environments, and provide tools for medical professionals to better care for patients.
Our Team
Dr. Rahul Kushwah
COO, Director
PhD, Banting Fellow. Developed world’s first genetic test for cannabis pharmacogenetics. Previously on the National Research Council for the Government of Canada in Human Health Therapeutics. Expertise in human diseases, genetics, immunology and regenerative/personalized
Sheldon Kales
CEO, Director
Expertise in operations, business strategy and capital markets. Held leadership roles operating R&D companies in the USA, Canada and the Middle East. Led companies from start-up stages through growth and successful
Rajiv Muradia
VP of Technology
Mobilewellbeing Founder. Executive entrepreneur with experience in technology, management and business development. Successfully founded several companies and has helped a number of start-ups with their product strategy, positioning and technology
Ajit Kumar
Director
Seasoned healthcare business leader. Founder of K-Med Ltd.; among the largest suppliers of healthcare and medical equipment in the UK with operations in the Middle East, EU and
Recent Press
Predictmedix AI Achieves Significant Milestones in Mental Health Detection and Analysis
Toronto, Ontario – December 5th, 2023 – Predictmedix AI Inc. (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) (the “Company” or “Predictmedix”), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI) is proud to announce ground-breaking achievements in the realm of mental health detection and analysis. With a commitment to advancing healthcare through […]
Predictmedix AI Announces Successful Clinical Validation at the University of Raharja, Indonesia, Demonstrating 95% Accuracy in Vital Sign Detection
Toronto, Ontario – November 14, 2023 – Predictmedix AI Inc. (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) (the “Company” or “Predictmedix”), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI) is proud to announce the results of a clinical validation conducted in collaboration with the esteemed University of Raharja in Indonesia. Clinical […]
Predictmedix AI Unveils Safe Entry Stations to Delegates from 30 Nations at D-30 Event in New Delhi
Toronto, Ontario – November 6, 2023 – Predictmedix AI Inc. (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) (the “Company” or “Predictmedix”), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI) is proud to announce that it introduced its state-of-the-art Safe Entry Stations to delegates from 30 countries during the D-30 event in […]
